3^rd International Conference on Cytopathology & Histopathology June 21-22, 2017 Philadelphia, Pennsylvania, USA

Erozen is Professor Emeritus of Pathology, The Johns Hopkins University. He has been an active member of the American Society of Cytopathology. He has served the Society in multiple capacities including President. He has been a leader in the area of fine needle aspiration, one of the major new areas in Cytopathology in the last twenty-five years. His research interest in pulmonary pathology has involved the application of molecular probes to cytologic specimens. His papers have been published in significant journals of his specialty and he has been an Associate Editor for Acta Cytologica since 1992.

Pulmonary pathology has involved the application of molecular probes to cytologic specimens, fine needle aspiration.

Rana Hoda is Chief of the Papanicolaou Cytology Laboratory and Director of the Cytopathology fellowship training program. Her primary clinical focus is cytopathology with special expertise in performing ultrasound-guided fine needle aspiration, urinary and gynecologic cytology and her research interests include ancillary tests in cytopathology and liquid based cytology among others. Hoda has published over 100 scientific papers, has published two text books including The Fundamentals of Pap Test Cytology. She is on the editorial board of several cytolopathology journals including Diagnostic Cytopathology, Journal of American Society of Cytopathology and Cytojournal.

Her primary clinical focus is cytopathology with special expertise in performing ultrasound-guided fine needle aspiration, urinary and gynecologic cytology and her research interests include ancillary tests in cytopathology and liquid based cytology among others.

Yun Gong is professor, The University of Texas MD Anderson Cancer Center. Her primary clinical focus is to have a strong interest in breast cancer research, especially predictive and prognostic markers. Gong has published over hundreds of scientific papers with invited articles and book chapters. She has played major role (as first author and PI) in most of the research studies.

Strong interest in breast cancer research, especially predictive and prognostic markers

James P. Basilion is Professor of Radiology, Biomedical Engineering, Case Western Reserve University. He has been the Co-Director of the Cancer Imaging Program at the Case Comprehensive Cancer Center since its inception. He now is a tenured full professor in both the Departments of Radiology (SOM) and the department of Biomedical Engineering (Case School of Engineering). For the last 2 years he has been the Director of the Case Center for Imaging Research and the Vice Chair of Basic Sciences Research for the Department of Radiology. He is working to develop a much desired clinical translational infrastructure to service the Center’s molecular imaging pipeline. He reviews for several academic journals, serves as an External Advisory Board Member for the Pacific Ovarian Cancer Research Consortium, the Breast Cancer (Ad Hoc) research programs, and was a standing member on the MEDI Study Section for NIH and has just accepted appointment onto the CMIP study section. He holds several editorial board positions for Molecular Imaging centric journals.

-Imaging Transferrin Receptor Expression. *In vivo Imaging of Human Schistosome Parasites. *Enhanced Detection of Breast Tumors by MR imaging. -Multiplexed Imaging of Molecular Targets. *Intra-Operative Molecular Imaging.

Li is an internationally recognized expert in the field of cytopathology and co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. Dr. Li also serves as editorial board members for several journals, committee member of the American Society of Cytopathology, and study sections of government agents and private organizations. She has more than 70 publications and book chapters. Dr. Li is also the editor of “Diagnostic Cytopathology Board Review and Self-Assessment”.

She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers

Irina Shabalova has got her MD degree in Moscow Medical Institute, PhD in 1986 from Cancer Research Centre by P.N.Herzen, Sc.D. degree in 2002. Her practice as clinical cytologist begins from 1975. Positions: Unior Researcher, P.A. Herzens’Cancer Research Centre, Associate Professor, Central Institute of Postgraduated Education, Senior Researcher, N.N. Blokhin Cancer Research Centre, 2003 - Professor, Russian Medical Academy of Postgraduated Education. She has published more than 140 papers, 9 books. An editorial board member of the journals “Clinical Laboratory Diagnostics”, “Laboratory” (Russia), advisory board member of the “Cytopathology” (GB). MIAC, president of the Russian Association of Clinical Cytologists.

Her research area includes clinical cytology